Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism

被引：0
作者：
Hui-Yan Shi
Jin Yan
Wen-Hui Zhu
Guo-Ping Yang
Zhi-Rong Tan
Wei-Hua Wu
Gan Zhou
Xiao-Ping Chen
Dong-Sheng Ouyang
机构：
[1] Central South University,Pharmacogenetics Research Institute, Institute of Clinical Pharmacology
[2] Central South University,Third Xiangya Hospital
[3] Central South University,Department of Pharmacology, School of Pharmaceutical Science
来源：
European Journal of Clinical Pharmacology | 2010年 / 66卷
关键词：
Voriconazole; Erythromycin; CYP2C19; Genetic polymorphism; Chinese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1131 / 1136
页数：5
相关论文
共 50 条
  • [41] Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
    Hanioka, N.
    Tsuneto, Y.
    Saito, Y.
    Sumada, T.
    Maekawa, K.
    Saito, K.
    Sawada, J.
    Narimatsu, S.
    [J]. XENOBIOTICA, 2007, 37 (04) : 342 - 355
  • [42] Association of CYP2C19, CYP3A4 and ABCC2 polymorphisms and voriconazole plasma concentrations in Uygur pediatric patients
    Zhao, Ting
    Shen, Hao
    Zhang, Hui-lan
    Feng, Jie
    Liu, Si-ming
    Wang, Ting-ting
    Li, Hong-jian
    Yu, Lu-hai
    [J]. PHARMACOGENOMICS, 2023, 24 (03) : 141 - 151
  • [43] Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone
    Byeon, Ji-Young
    Cho, Chang-Keun
    Kang, Pureum
    Kim, Se-Hyung
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (08) : 713 - 721
  • [44] Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone
    Ji-Young Byeon
    Chang‑Keun Cho
    Pureum Kang
    Se-Hyung Kim
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    [J]. Archives of Pharmacal Research, 2023, 46 (8) : 713 - 721
  • [45] Effects of CYP2C19, CYP2C9 and CYP3A4 gene polymorphisms on plasma voriconazole levels in Chinese pediatric patients
    Fan, Xinghua
    Zhang, Hong
    Wen, Zhipeng
    Zheng, Xiaoli
    Yang, Yi
    Yang, Jihong
    [J]. PHARMACOGENETICS AND GENOMICS, 2022, 32 (04) : 152 - 158
  • [46] Effect of CYP2C19 Polymorphisms on Plasma Voriconazole Concentration in Patients with Immunodeficiency Disease
    Huang, Yingying
    Xu, Jian
    Kong, Lingti
    Liu, Lin
    Zhang, Feng
    Zhu, Yulin
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 : 13 - 21
  • [47] Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections
    Hamadeh, Issam S.
    Klinker, Kenneth P.
    Borgert, Samuel J.
    Richards, Ashley I.
    Li, Wenhui
    Mangal, Naveen
    Hiemenz, John W.
    Schmidt, Stephan
    Langaee, Taimour Y.
    Peloquin, Charles A.
    Johnson, Julie A.
    Cavallari, Larisa H.
    [J]. PHARMACOGENETICS AND GENOMICS, 2017, 27 (05) : 190 - 196
  • [48] Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes
    Hicks, J. Kevin
    Crews, Kristine R.
    Flynn, Patricia
    Haidar, Cyrine E.
    Daniels, Calvin C.
    Yang, Wenjian
    Panetta, John C.
    Pei, Deqing
    Scott, Jeffrey R.
    Molinelli, Alejandro R.
    Broeckel, Ulrich
    Bhojwani, Deepa
    Evans, William E.
    Relling, Mary V.
    [J]. PHARMACOGENOMICS, 2014, 15 (08) : 1065 - 1078
  • [49] Reply to: Letter to the Editor "Impact of the CYP2C19*17 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Proton Pump Inhibitors"
    Jiang, Fen
    Shin, Jae-Gook
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (03) : 360 - 360
  • [50] Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
    Kim, K. -A.
    Song, W. -K.
    Kim, K. -R.
    Park, J. -Y.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 697 - 703
12345